Optogenetics-induced activation of glutamate receptors improves memory function in mice with Alzheimer’s disease

Optogenetics is a combination of optics and genetics technology that can be used to activate or inhibit specific cells in tissues. It has been used to treat Parkinson’s disease, epilepsy and neurological diseases, but rarely Alzheimer’s disease. Adeno-associated virus carrying the CaMK promoter driv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ke-Wei, Ye, Xiao-Lin, Huang, Ting, Yang, Xi-Fei, Zou, Liang-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788230/
https://www.ncbi.nlm.nih.gov/pubmed/31397354
http://dx.doi.org/10.4103/1673-5374.262593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788230/
https://www.ncbi.nlm.nih.gov/pubmed/31397354
http://dx.doi.org/10.4103/1673-5374.262593

Ejemplares similares